Processa Pharmaceuticals
PCSA
PCSA
18 hedge funds and large institutions have $376K invested in Processa Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$49.9K | |
| 2 | +$26.6K | |
| 3 | +$25.7K | |
| 4 |
Two Sigma Investments
New York
|
+$6.25K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$4.26K |
Top Sellers
| 1 | -$107K | |
| 2 | -$36.7K | |
| 3 | -$10.3K | |
| 4 |
Millennium Management
New York
|
-$6.61K |
| 5 |
MCP
Mirador Capital Partners
Pleasanton,
California
|
-$4.88K |